Forward Therapeutics, Inc., a pioneering biopharmaceutical company committed to transforming the treatment of chronic inflammatory disorders, today announced the appointment of Vincent Aurentz to its board of directors.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
